These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28925090)

  • 1. Simplifying medication administration: From daily ingestion to monthly injection.
    Citrome L
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28925090
    [No Abstract]   [Full Text] [Related]  

  • 2. An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
    Robinson MR; Denis L; Mahler C; Walker K; Stitch R; Lunglmayr G
    Eur J Surg Oncol; 1985 Jun; 11(2):159-65. PubMed ID: 3159598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Athayde C; Noronha CF; de Melo NR; Cabral ZA; Almeida JA; da Silva BL; Neto JS; Rumi DO
    Contraception; 2006 Mar; 73(3):249-52. PubMed ID: 16472564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between one injection and three monthly injections of intravitreal bevacizumab for myopic choroidal neovascularization.
    Niwa Y; Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Ophthalmic Res; 2012; 47(3):135-40. PubMed ID: 22042059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study.
    Campochiaro PA; Wykoff CC; Singer M; Johnson R; Marcus D; Yau L; Sternberg G
    Ophthalmology; 2014 Dec; 121(12):2432-42. PubMed ID: 25060610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of less frequent injections in advanced prostate cancer.
    Ortiz M
    Aust Fam Physician; 2015 Jun; 44(6):429-30. PubMed ID: 26209999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance-oriented prescribing: simplifying drug regimens.
    Fischer RG
    J Fam Pract; 1980 Mar; 10(3):427-35. PubMed ID: 6986449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monthly shots may replace daily anti-HIV pills.
    Cohen J
    Science; 2018 Aug; 361(6404):740. PubMed ID: 30139854
    [No Abstract]   [Full Text] [Related]  

  • 9. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacromial triamcinolone acetonide, hyaluronic acid and saline injections for shoulder pain an RCT investigating the effectiveness in the first days.
    Penning LI; de Bie RA; Walenkamp GH
    BMC Musculoskelet Disord; 2014 Oct; 15():352. PubMed ID: 25341673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly injectable naltrexone for pathological gambling.
    Yoon G; Kim SW
    Am J Psychiatry; 2013 Jun; 170(6):682-3. PubMed ID: 23732971
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
    Eisman JA; Civitelli R; Adami S; Czerwinski E; Recknor C; Prince R; Reginster JY; Zaidi M; Felsenberg D; Hughes C; Mairon N; Masanauskaite D; Reid DM; Delmas PD; Recker RR
    J Rheumatol; 2008 Mar; 35(3):488-97. PubMed ID: 18260172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monthly injection provides new contraceptive choice.
    FDA Consum; 2001; 35(1):5. PubMed ID: 11930928
    [No Abstract]   [Full Text] [Related]  

  • 14. Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Ibach K; Preuss J
    Rheumatology (Oxford); 2003 Jun; 42(6):743-9. PubMed ID: 12730532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two intensified conventional insulin regimens with three and four daily injections.
    Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
    Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of twice-daily injection with insulin glargine: a case report and review of the literature.
    Youssef D; El Abbassi A; Woodby G; Peiris AN
    Tenn Med; 2010 Feb; 103(2):42-3. PubMed ID: 20345066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Further characterization between oral bisphosphonate dosing interval and patient preference--patient preference for daily, weekly and monthly bisphosphonate, based on results of 3,052 outpatients questionnaires].
    Ijiri S
    Nihon Rinsho; 2013 Dec; 71(12):2223-31. PubMed ID: 24437282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
    Osaka R; Muraoka Y; Miwa Y; Manabe K; Kobayashi M; Takasago Y; Ooto S; Murakami T; Suzuma K; Iida Y; Tsujikawa A
    Ophthalmologica; 2018; 239(1):27-35. PubMed ID: 28946138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. If one daily injection of IGF-I has the same growth-promoting effect as 2 injections per day, why continue to give two injections?
    Laron Z
    Pediatr Endocrinol Rev; 2013; 10(3):277-9. PubMed ID: 23724434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
    Russig H; Murphy CA; Feldon J
    Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.